Epitalon is a prescription therapy used for healthy aging support

Patients seeking support for healthy aging support may qualify after evaluation by a licensed provider.

Yes. Epitalon is a compounded peptide requiring a valid prescription from a licensed provider.

Injection site reactions including transient redness, mild swelling, or discomfort may occur with subcutaneous administration. Some patients report mild fatigue or drowsiness, consistent with Epitalon's influence on melatonin and circadian rhythm — this typically resolves as the body adjusts. Temporary changes in sleep architecture, including deeper or more vivid sleep, have been noted during initial dosing cycles. As with any peptide therapy, individual responses vary. Report any unusual or persistent symptoms to your provider.

Epitalon is not appropriate for patients who are pregnant or breastfeeding, as safety data in these populations is insufficient. Patients with a personal or family history of hormone-sensitive cancers should consult their provider before use, as telomerase activation theoretically supports proliferation in malignant cell lines. Those with active autoimmune conditions require individualized provider review, as immune modulation may alter disease activity. Epitalon has not been studied in pediatric populations and is not indicated for patients under 18. Disclose your full medical history, current medications, and any history of malignancy before starting treatment.

Formal drug interaction studies for Epitalon have not been conducted. Epitalon modulates the HPA axis and pineal melatonin output — patients already taking melatonin supplements, corticosteroids, or medications affecting cortisol regulation should discuss concomitant use with their provider. Because Epitalon influences immune function, caution is warranted in patients on immunosuppressive therapy, as effects may be additive or antagonistic depending on the agent. Patients on hormone therapy, including TRT or thyroid medications, should disclose this before starting, as Epitalon may influence gonadotropin and pituitary signaling. Always provide a complete medication list to your provider before beginning treatment.

Patients with a history of any malignancy should not use Epitalon without thorough oncological and provider evaluation, as telomerase activation may theoretically support proliferation in residual or occult malignant cells. Those with autoimmune conditions, hormone-sensitive disorders, or active infections require individualized review before starting, as Epitalon's immune-modulatory and hormonal effects may interact with underlying disease activity. Patients with significant cardiovascular, hepatic, or renal conditions should disclose their full history, as these populations were not included in available clinical studies. Your provider requires a complete medical history before prescribing and will determine whether Epitalon is appropriate given your individual health profile.